Bellwether Advisors’s Standard BioTools LAB Stock Holding History

Bellwether Advisors’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,016	Closed	-$2.42K	–	370
2025 Q2	$2.42K	Hold	2,016	–	–	﹤0.01%	485
2025 Q1	$2.18K	Hold	2,016	–	–	﹤0.01%	429
2024 Q4	$3.53K	Buy	+2,016	New	+$3.75K	﹤0.01%	408
2023 Q2	–	Sell	-2,016	Closed	-$3.93K	–	283
2023 Q1	$3.93K	Hold	2,016	–	–	﹤0.01%	318
2022 Q4	$2.36K	Hold	2,016	–	–	﹤0.01%	347
2022 Q3	$2K	Hold	2,016	–	–	﹤0.01%	392
2022 Q2	$3K	Hold	2,016	–	–	﹤0.01%	316
2022 Q1	$7K	Hold	2,016	–	–	﹤0.01%	335
2021 Q4	$7K	Hold	2,016	–	–	﹤0.01%	361
2021 Q3	$13K	Hold	2,016	–	–	﹤0.01%	284
2021 Q2	$12K	Hold	2,016	–	–	﹤0.01%	256
2021 Q1	$9K	Hold	2,016	–	–	﹤0.01%	259
2020 Q4	$12K	Buy	+2,016	New	+$13.2K	0.01%	223

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Bellwether Advisors's LAB Position: Q3 2025 in Review

Bellwether Advisors sold out of Standard BioTools (LAB) in Q3 2025, closing a stake of 2,016 shares — an estimated $2.42K sold.

Bellwether Advisors first reported a position in LAB in Q4 2020 and held it in 13 quarters. The position peaked at $13K in Q3 2021. 155 funds tracked by Wall St. Rank hold LAB as of Q3 2025.

Bellwether Advisors reported no remaining Standard BioTools position as of Q3 2025 after selling out during the quarter.
Bellwether Advisors sold 2,016 Standard BioTools shares in Q3 2025, an estimated $2.42K.
Bellwether Advisors first reported a position in Standard BioTools in Q4 2020 and held it in 13 quarters.
Bellwether Advisors's Standard BioTools position peaked at $13K in Q3 2021.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2025.

Based on Bellwether Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.